(UroToday.com) The 2021 European Association of Urology (EAU) Annual meeting’s Confederación Americana de Urología lecture was provided by Dr. Alejandro R. Rodriguez discussing the role of TUR in muscle invasive bladder cancer (MIBC). Dr. Rodriguez started by highlighting that bladder cancer is the 10th most commonly diagnosed cancer worldwide with 573,000 new cases and 213,000 deaths. Bladder cancer is more common in men than in women with an incidence of 9.5 per 100,000 men, a mortality of 3.3 per 100,000 men, and approximately four times more common than women globally. Bladder cancer includes three categories that differ in terms of prognosis, management, and treatment aims specifically to non-muscle invasive disease, muscle invasive disease, and metastatic disease.